TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive In Brief: Chabner Names DCT Acting Director, Schepartz Returns To Deputy Job; GM Winners Announced July 3, 1981
